Citations 3
Advances in Retinal Therapeutics
Carvounis, Petros , Albini, Thomas A. , Tsilimbaris, Miltiadis K. , Barkmeier, Andrew J. , Tsilimbaris, Miltiadis
Journal of Ophthalmology | March 9, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-1
Retinal Pigment Epithelial Tears and the Management of Exudative Age-Related Macular Degeneration
Carvounis, Petros , Barkmeier, Andrew J.
Seminars in Ophthalmology | May 24, 2011 | Volume: 26 | Issue: 3 | Pages: 94-103
Regression of Serous Macular Detachment Due to Peripheral Exudative Hemorrhagic Chorioretinopathy following Intravitreal Bevacizumab
Kadikoy, Hüseyin, Holz, Eric R. , Carvounis, Petros , Barkmeier, Andrew J.
European Journal of Ophthalmology | January 14, 2011 | Volume: 21 | Issue: 4 | Pages: 506-508
Purpose TO describe a case of exudative macular detachment secondary to peripheral exudative chorioretinopathy with a favorable anatomic and visual outcome following treatment with intravitreal bevacizumab. Methods The medical records of a patient with peripheral exudative chorioretinopathy were reviewed. Results Macular reattachment was achieved with a corresponding visual acuity improvement that was maintained over an uncomplicated 17-month clinical course. Conclusions Bevacizumab may be an effective treatment option for exudative macular detachment secondary to peripheral exudative hemorrhagic chorioretinopathy.